21 research outputs found

    Monopole characteristics in various Abelian gauges

    Get PDF
    Renormalization group (RG) smoothing is employed on the lattice to investigate and to compare the monopole structure of the SU(2) vacuum as seen in different gauges (maximally Abelian (MAG), Polyakov loop (PG) and Laplacian gauge (LG)). Physically relevant types of monopoles (LG and MAG) are distinguished by their behavior near the deconfining phase transition. For the LG, Abelian projection reproduces well the gauge independent monopole structure encoded in an auxiliary Higgs field. Density and localization properties of monopoles, their non-Abelian action and topological charge are studied. Results are presented confirming the Abelian dominance with respect to the non-perturbative static potential for all gauges considered.Comment: 36 pages, 12 figure

    Quark zero modes in intersecting center vortex gauge fields

    Get PDF
    The zero modes of the Dirac operator in the background of center vortex gauge field configurations in R2\R^2 and R4\R^4 are examined. If the net flux in D=2 is larger than 1 we obtain normalizable zero modes which are mainly localized at the vortices. In D=4 quasi-normalizable zero modes exist for intersecting flat vortex sheets with the Pontryagin index equal to 2. These zero modes are mainly localized at the vortex intersection points, which carry a topological charge of ±1/2\pm 1/2. To circumvent the problem of normalizability the space-time manifold is chosen to be the (compact) torus \T^2 and \T^4, respectively. According to the index theorem there are normalizable zero modes on \T^2 if the net flux is non-zero. These zero modes are localized at the vortices. On \T^4 zero modes exist for a non-vanishing Pontryagin index. As in R4\R^4 these zero modes are localized at the vortex intersection points.Comment: 20 pages, 4 figures, LaTeX2e, references added, treatment of ideal vortices on the torus shortene

    Abelian Monopole and Center Vortex Views at the Multi-Instanton Gas

    Get PDF
    We consider full non-Abelian, Abelian and center projected lattice field configurations built up from random instanton gas configurations in the continuum. We study the instanton contribution to the QˉQ\bar{Q}Q force with respect to ({\it i}) instanton density dependence, ({\it ii}) Casimir scaling and ({\it iii}) whether various versions of Abelian dominance hold. We check that the dilute gas formulation for the interaction potential gives an reliable approximation only for densities small compared to the phenomenological value. We find that Casimir scaling does not hold, confirming earlier statements in the literature. We show that the lattice used to discretize the instanton gas configurations has to be sufficiently coarse (a≈2ρˉa \approx 2\bar{\rho} compared with the instanton size ρˉ\bar{\rho}) such that maximal Abelian gauge projection and center projection as well as the monopole gas contribution to the QˉQ\bar{Q}Q force reproduce the non-Abelian instanton-mediated force in the intermediate range of linear quasi-confinement. We demonstrate that monopole clustering also depends critically on the discretization scale confirming earlier findings based on monopole blocking.Comment: 21 pages, 22 Postscript figure

    Abelian-Projected Effective Gauge Theory of QCD with Asymptotic Freedom and Quark Confinement

    Get PDF
    We give an outline of a recent proof that the low-energy effective gauge theory exhibiting quark confinement due to magnetic monopole condensation can be derived from QCD without any specific assumption. We emphasize that the low-energy effective abelian gauge theories obtained here give the dual description of the same physics in the low-energy region. They show that the QCD vacuum is nothing but the dual (type II) superconductor.Comment: 15 pages, Latex, no figures, Talk given at YKIS'97, Non-perturbative QCD, Kyot

    Abelian-Projected Effective Gauge Theory of QCD with Asymptotic Freedom and Quark Confinement

    Get PDF
    Starting from SU(2) Yang-Mills theory in 3+1 dimensions, we prove that the abelian-projected effective gauge theories are written in terms of the maximal abelian gauge field and the dual abelian gauge field interacting with monopole current. This is performed by integrating out all the remaining non-Abelian gauge field belonging to SU(2)/U(1). We show that the resulting abelian gauge theory recovers exactly the same one-loop beta function as the original Yang-Mills theory. Moreover, the dual abelian gauge field becomes massive if the monopole condensation occurs. This result supports the dual superconductor scenario for quark confinement in QCD. We give a criterion of dual superconductivity and point out that the monopole condensation can be estimated from the classical instanton configuration. Therefore there can exist the effective abelian gauge theory which shows both asymptotic freedom and quark confinement based on the dual Meissner mechanism. Inclusion of arbitrary number of fermion flavors is straightforward in this approach. Some implications to lower dimensional case will also be discussed.Comment: 39 pages, Latex, no figures, (2.2, 4.1, 4.3 are modified; 4.4, Appendices A,B,C and references are added. No change in conclusion

    A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET

    Full text link
    Tariquidar, a potent, nontoxic, third-generation P-glycoprotein (P-gp) inhibitor, is a possible reversal agent for central nervous system drug resistance. In animal studies, tariquidar has been shown to increase the delivery of P-gp substrates into the brain by severalfold. The aim of this study was to measure P-gp function at the human blood-brain barrier (BBB) after tariquidar administration using PET and the model P-gp substrate (R)-(11)C-verapamil. METHODS: Five healthy volunteers underwent paired (R)-(11)C-verapamil PET scans and arterial blood sampling before and at 2 h 50 min after intravenous administration of tariquidar (2 mg/kg of body weight). The inhibition of P-gp on CD56-positive peripheral lymphocytes of each volunteer was determined by means of the (123)Rh efflux assay. Tariquidar concentrations in venous plasma were quantified using liquid chromatography/mass spectrometry. RESULTS: Tariquidar administration resulted in significant increases (Wilcoxon test for paired samples) in the distribution volume (DV, +24% +/- 15%) and influx rate constant (K(1), +49% +/- 36%) of (R)-(11)C-verapamil across the BBB (DV, 0.65 +/- 0.13 and 0.80 +/- 0.07, P = 0.043; K(1), 0.034 +/- 0.009 and 0.049 +/- 0.009, P = 0.043, before and after tariquidar administration, respectively). A strong correlation was observed between the change in brain DV after administration of tariquidar and tariquidar exposure in plasma (r = 0.90, P = 0.037). The mean plasma concentration of tariquidar achieved during the second PET scan (490 +/- 166 ng/mL) corresponded to 100% inhibition of P-gp function in peripheral lymphocytes. CONCLUSION: Tariquidar significantly increased brain penetration of (R)-(11)C-verapamil-derived activity due to increased influx. As opposed to peripheral P-gp function, central P-gp inhibition appeared to be far from complete after the administered tariquidar dose

    Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior—A case report

    No full text
    Abstract Due to differences in the protein folding mechanisms, it is exceedingly rare for amyloid light chain (AL) amyloidosis and monoclonal gammopathy of renal significance (MGRS) to coexist. We herein report the first case of concurrent AL amyloidosis and a subclass of MGRS, light chain proximal tubulopathy (LCPT). The 53‐year‐old female was diagnosed with smoldering myeloma immunoglobulin G kappa and AL amyloidosis with deposits in fat and gastrointestinal tissue. The kidney biopsy did not show amyloid deposits but electron microscopy revealed the presence of LCPT with crystal formation in proximal tubular epithelial cells. This case illustrates the complex pathophysiology of protein deposition in monoclonal gammopathies
    corecore